AXNX Chart
- 52-Week Range: $47.99 - $67.47
- Market Capitalization: $2.91B
- Short Percentage: 0%
- Target Price: $68.57
- Shares Outstanding: 50.66M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
AXNX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemBusiness Wire | January 31st
- Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue GuidanceBusiness Wire | January 11th
- Axonics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceBusiness Wire | December 21st
- Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemBusiness Wire | December 13th
Company Info
Website: https://www.axonics.com
Address: 26 Technology Drive, Irvine, CA, United States, 92618
Sector: Healthcare
Industry: Medical Devices
Full time employees: 610
Address: 26 Technology Drive, Irvine, CA, United States, 92618
Sector: Healthcare
Industry: Medical Devices
Full time employees: 610
$AXNX due for a spike!
$AXNX what V recovery or fake pump
$AXNX buying a share monday LFG
$AXNX coming now
$AXNX cup and handle dont play
$AXNX Guys when can we expect that 30% drop?
$AXNX a comeback is always more fun than an all out win!!!!
$AXNX said y’all dumb af
$AXNX holding and buying these dips is so easy.
$AXNX oversold